CBIO CIK: 1253689

Crescent Biopharma Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.4
FY22:
−47.4
FY23:
−39.3
FY24:
−40.0
FY25:
−153
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−150
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−152
(positive)
Change from FY21 to FY25
millions USD
FY21:
−63.4
FY22:
−46.7
FY23:
−36.9
FY24:
−37.9
FY25:
−154

All amounts in millions USD Data sources:SEC EDGARTwelve Data